by John Conrad | Dec 3, 2020 | Member News
Orphazyme A/S (ORPHA.CO; ORPH), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announced it has established its U.S. headquarters in Chicago, today announced it has...
by John Conrad | Mar 31, 2020 | COVID, Member News
BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this...
by John Conrad | Feb 12, 2020 | Member News
Technology hub will support 48,000 new economy jobs, with $19 billion economic impact over the next 10 years; University of Illinois Board of Trustees Chairman Edwards and his wife, Anne also give $10 Million to University, half of which will go to IIN and DPI...
by John Conrad | Jan 10, 2020 | Member News
Trammell Crow Company (TCC), one of the largest commercial real estate developers in the United States, is developing Fulton Labs, a best-in-class life sciences laboratory and office building in Chicago’s Fulton Market neighborhood. The new 400,000-square-foot...
by John Conrad | Dec 10, 2019 | iBIO News, Policy News
Last night in a speech at the Economic Club of Chicago, Mayor Lightfoot discussed her 10 year economic development strategy for Chicago focusing on seven industry clusters. The clusters are split into two main categories. Foundational clusters includes industries like...